Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Lannett Submits IND With FDA For Pivotal Clinical Trial Of Biosimilar Insulin Glargine


RTTNews | Dec 20, 2021 06:56AM EST

06:56 Monday, December 20, 2021 (RTTNews) - Lannett Submits IND With FDA For Pivotal Clinical Trial Of Biosimilar Insulin Glargine

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC